First trial of mAb targeting anti-Müllerian human receptor II tested in oncology patients
Initial results expected in 2017
GamaMabs Pharma starts phase Ia/Ib study of first-in-class monoclonal antibody GM102 in advanced gynecological cancer
Category Archives: Non classé